2013-05-06T13:10:49-05:00 2012-12-31 042088368 GRAY GRAY & GRAY LLP 34 SOUTHWEST PARK WESTWOOD MA 020901548 990 2012-01-01 522396428 ALZHEIMER'S DISEASE RESEARCH FOUNDATION CURE ALZHEIMER'S FUND ALZH 7812373800 34 WASHINGTON ST NO 200 WELLESLEY MA 02481 TIMOTHY W ARMOUR 7812373800 2013-03-12 1 RICHARD D TARDIFF P00154902 7814070300 2013-03-12 2012 2016-03-07 17:11:31Z TIMOTHY W ARMOUR 21 SUNSET ROAD WESTON MA 02493 11813633 0 X WWW.CUREALZ.ORG X 2004 PA TO FUND RESEARCH WITH THE HIGHEST PROBABILITY OF PREVENTING, SLOWING OR REVERSING ALZHEIMER'S DISEASE THROUGH VENTURE BASED PHILANTRHOPY WITH ALL ORGANIZATIONAL EXPENSES PAID BY THE BOARD, ALLOWING ALL PUBLIC CONTRIBUTIONS TO DIRECTLY FUND ALZHEIMER'S RESEARCH. 6 5 7 24 0 0 4682190 9103453 0 0 5084 11166 0 13447 4687274 9128066 2052500 3341898 0 0 445931 608099 0 0 267824 624839 1034405 3123270 4984402 1564004 4143664 4601371 8871081 50903 176842 4550468 8694239 FUND RESEARCH WITH THE HIGHEST PROBABILITY OF PREVENTING, SLOWING OR REVERSING ALZHEIMER'S DISEASE THROUGH VENTURE BASED PHILANTHROPY WITH ALL ORGANIZATIONAL EXPENSES PAID BY THE BOARD, ALLOWING ALL PUBLIC CONTRIBUTIONS TO DIRECTLY FUND ALZHEIMER'S RESEARCH. 0 0 3341898 3341898 IN 2012, CURE ALZHEIMER'S FUND FUNDED FOURTEEN RESEARCH PROJECTS AT NINE LEADING ACADEMIC ALZHEIMER'S RESEARCH LABORATORIES IN THE UNITED STATES. EACH OF THESE GRANTS HAD THE OBJECTIVE OF LEARNING MORE ABOUT THE ORIGINS OF THE DISEASE, UNDERSTANDING MORE ABOUT THE PROGRESSION OF THE PATHOLOGY OR DEVELOPING DRUGS TO STOP THE DISEASE. 821989 SUPPORT OF THE GRANTING PROCESS AND CREATING AWARENESS FOR THE NEED FOR MORE RESEARCH TOOK THE FORM OF MEETINGS OF THE RESEARCH CONSORTIUM TO REVIEW AND MODIFY CURE ALZHEIMER'S FUND'S RESEARCH AGENDA, SUPPORT OF THE SCIENTIFIC ADVISORY BOARD IN REVIEWING PROPOSALS AND MEETINGS, MAILINGS AND SUPPORT OF THIRD PARTY EVENTS DESIGNED TO RAISE AWARENESS ABOUT THE NEED OF MORE RESEARCH INTO THE ORIGINS AND PROGRESSION OF ALZHEIMER'S DISEASE. 167814 CURE ALZHEIMER'S FUND SERVES AS FIDUCIARY AGENT FOR A SERIES OF INDEPENDENTLY PRODUCED VIDEOS ABOUT ALZHEIMER'S DISEASE. WITH AN INDEPENDENT EXECUTIVE PRODUCER UNAFFILIATED WITH CURE ALZHEIMER'S FUND, THE FOUNDATION'S ROLE IS TO RECEIVE FUNDS FROM THE METROPOLITAN LIFE FOUNDATION, DISPENSE THEM AS APPROVED BY THE EXEUCTIVE PRODUCER AND REPORT THE FINANCIAL ACTIVITY PERIODICALLY TO THE METROPOLITAN LIFE FOUNDATION. 4331701 1 1 0 1 0 0 0 0 0 0 1 0 0 0 1 1 1 0 0 0 0 0 0 0 0 0 0 1 0 1 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 1 20 0 7 1 0 0 0 0 0 0 0 0 X 6 5 1 0 0 0 0 0 0 1 1 0 0 1 1 1 1 1 1 1 1 0 MA AL AK AS AZ AR CA CO CT DE DC FM FL GA GU HI ID IL IN IA KS KY LA ME MH MD MI MN MS MO MT NE NV NH NJ NM NY NC ND MP OH OK OR PW PA PR RI SC SD TN TX UT VT VI VA WA WV WI WY X X TIMOTHY W ARMOUR 7812373800 34 WASHINGTON STREET STE 200 WELLESLEY MA 02481 JEFFREY MORBY 2.00 X 0 0 0 JACQUELINE MORBY 5.00 X 0 0 0 HENRY MCCANCE 1.00 X 0 0 0 PHYLLIS RAPPAPORT 1.00 X 0 0 0 ROBERT GREENHILL 1.00 X 0 0 0 TIMOTHY W ARMOUR 40.00 X X 0 193965 3092 MICHAEL F CURREN 40.00 X 0 145000 0 SALLY G ROSENFIELD 40.00 X 0 117432 363 0 456397 3455 0 0 1 0 DAVID SHENK 216 ST JOHNS PLACE APT D BROOKLYN NY 11217 PRESENTOR/ADVISOR 178621 1 9103453 2685567 9103453 1598 1598 2695135 2685567 9568 9568 9568 OTHER INCOME 900099 13447 13447 13447 9128066 23015 0 1598 3341898 3341898 505749 254987 127031 123731 59001 7450 32445 19106 6679 3162 1971 1546 3454 1472 1291 691 33216 15944 8747 8525 5487 5487 77300 77300 5625 2875 2750 22471 22471 4212 4212 2752 2752 46054 46054 42905 28322 3993 10590 9439 6662 2777 14180 14180 1955 1955 INFORMATION AND AWARENE 480393 447440 32953 DOCUMENTARIES 167814 167814 GOVERNMENT RELATIONS 36000 36000 MISCELLANEOUS 19150 1345 15760 2045 98668 19205 36047 43416 4984402 4331701 384877 267824 1328315 1575930 3029460 4626974 192993 2626500 1762 3320 35906 19897 26520 16009 308 228 22013 22120 4601371 8871081 31531 21737 19372 155105 50903 176842 X 4243791 5975506 306677 2718733 4550468 8694239 4601371 8871081 4143664 107 0 X 0 1 X 1 0 X 3042089 3339366 4039719 4763246 9103453 24287873 3042089 3339366 4039719 4763246 9103453 24287873 8988980 15298893 74626 20020 -5755 5084 11166 105141 -498 13447 12949 24405963 0.62690 0.59540 X RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 0 0 0 0 0 0 1 44321 0 0 44321 0 PART IV, SUPPLEMENTAL INFORMATION: PART II-B, LINE 1(I), OTHER LOBBYING ACTIVITIES: A REGISTERED LOBBYIST CONTACTED VARIOUS CONGRESSIONAL LEGISLATORS FOR THE PURPOSE OF ENCOURAGING INCREASED FUNDING OF ALZHEIMER'S DISEASE RESEARCH. 17926 8099 9827 17980 11798 6182 16009 ACCRUED EXPENSES 55105 UNEXPENDED AUTHORIZATIONS 100000 155105 X 9158892 107 30719 30826 9128066 0 9128066 5015121 30719 30719 4984402 0 4984402 DESCRIPTION OF UNCERTAIN TAX POSITIONS UNDER FIN 48: PART X, LINE 2: CAF WAS DETERMINED TO BE EXEMPT FROM FEDERAL INCOME TAX UNDER PROVISIONS OF SECTION 501(C)(3) OF THE INTERNAL REVENUE CODE OF 1986 (IRC) AND HAS BEEN CLASSIFIED AS AN ORGANIZATION THAT IS NOT A PRIVATE FOUNDATION AS DEFINED IN SECTION 509(A)(3) OF THE IRC. ACCORDINGLY, NO PROVISIONS FOR FEDERAL OR STATE INCOME TAXES ARE REQUIRED.CAF IS REQUIRED TO RECOGNIZE THE FINANCIAL STATEMENT IMPACT OF A TAX POSITION WHEN IT IS MORE LIKELY THAN NOT THAT THE POSITION WILL BE SUSTAINED UPON EXAMINATION. ANY INTEREST AND PENALTIES RECOGNIZED ASSOCIATED WITH A TAX POSITION WOULD BE CLASSIFIED AS CURRENT IN CAF'S FINANCIAL STATEMENTS. CURRENTLY, THE TAX YEARS ENDED DECEMBER 31, 2009, 2010, AND 2011 ARE OPEN AND SUBJECT TO EXAMINATION BY THE INTERNAL REVENUE SERVICE AND THE MASSACHUSETTS DEPARTMENT OF REVENUE. HOWEVER, CAF IS NOT CURRENTLY UNDER AUDIT NOR HAS CAF BEEN CONTACTED BY ANY OF THESE JURISDICTIONS. BASED ON THE EVALUATION OF CAF'S TAX POSITIONS, MANAGEMENT BELIEVES ALL POSITIONS TAKEN WOULD BE UPHELD UNDER AN EXAMINATION. THEREFORE, NO PROVISION FOR THE EFFECTS OF UNCERTAIN TAX POSITIONS HAS BEEN RECORDED FOR THE YEAR ENDED DECEMBER 31, 2012. 0 MASSACHUSETTS GENERAL HOSPITAL MGH AGING AND RESEARCH UNIT 114 16TH STREET CHARLESTOWN MA 02129 501C3 1200000 ALZHEIMER'S GENOME PROJECT MASSACHUSETTS GENERAL HOSPITAL MGH AGING AND RESEARCH UNIT 114 16TH STREET CHARLESTOWN MA 02129 501C3 300000 ANTI-MICROBIAL PEPTIDE (AMP)ANTI-MICROBIAL PEPTIDE (AMP) MASSACHUSETTS GENERAL HOSPITAL MGH AGING AND RESEARCH UNIT 114 16TH STREET CHARLESTOWN MA 02129 501C3 100000 GENERAL ANESTHETICS AND AD UNIVERSITY OF SOUTHERN CALIFORNIA 1501 SAN PABLO STREET LOS ANGELES CA 900892821 501C3 100000 THE ROLE OF PICALM IN ALCHEIMER'S DISEASE NORTHWESTERN UNIVERISTY 303 EAST CHICAGO AVENUE CHICAGO IL 606103008 501C3 100000 EPS HOMOLOGY DOMAIN (EHD) AND BACE1 UNIVERSITY OF CALIFORNIA LOS ANGELES 710 WESTWOOD PLAZA LOS ANGELES CA 90095 501C3 100000 ANTIBODY SIGNATURE/EARLY SCREENING UNIVERSITY OF CALIFORNIA SAN DIEGO 9500 GILMAN DRIVE LA JOLLA CA 92093 501C3 150000 NOVEL SOLUBLE GAMMA SECRETASE MODULATORS (GSM) THE UNIVERSITY OF CHICAGO 924 E 57TH STREET CHICAGO IL 60637 501C3 100000 BACE1 TRANSCYTOSIS THE ROCKEFELLER UNIVERSITY 1230 YORK AVENUE NEW YORK NY 10065 501C3 100000 IPS-DERIVED AND TRANS-DIFFERENTIATED HUMAN NEURONS BRIGHAM AND WOMEN'S HOSPITAL 77 AVENUE LOUIS PASTEUR BOSTON MA 02115 501C3 100000 AB OLIGOMERS AND TAU AGGREGATION BRIGHAM AND WOMEN'S HOSPITAL 77 AVENUE LOUIS PASTEUR BOSTON MA 02115 501C3 125000 RED BLOOD CELL CR1 LEVELS IN AB CLEARANCE THE UNIVERSITY OF CHICAGO 947 E 58TH STREET CHICAGO IL 60637 501C3 34728 TARGRETIN/BEXAROTENE INVESTIGATIONS TUFTS UNIVERSITY SCHOOL OF MEDICINE 136 HARRISON AVENUE BOSTON MA 02111 501C3 100000 UPD ANALOGS NORTHWESTERN UNIVERISTY 303 EAST CHICAGO AVENUE CHICAGO IL 606103008 501C3 15615 TARGRETIN/BEXAROTENE INVESTIGATIONS MASSACHUSETTS GENERAL HOSPITAL MGH AGING AND RESEARCH UNIT 114 16TH STREET CHARLESTOWN MA 02129 501C3 750000 WGS#1 X 0 0 0 0 0 0 0 0 0 TIMOTHY W ARMOUR 0 193965 0 0 0 0 0 0 0 3092 0 197057 0 0 PART I, LINE 3 A COMPENSATION COMMITTEE REVIEWS ALL COMPENSATION ANNUALLY. X 19 2685567 AVERAGE HIGH AND LOW 0 0 1 THIRD PARTY USE: PART I, LINE 32B: WHEN STOCK IS RECEIVED AS A CONTRIBUTION IT IS SOLD IMMEDIATELY UPON RECEIPT OR AS SOON THEREAFTER AS IS PRACTICAL THROUGH BANK OF NEW YORK/MELLON. FORM 990, PART VI, SECTION A, LINE 2 JEFFREY MORBY AND JACQUELINE MORBY ARE BOTH DIRECTORS AND SPOUSES. FORM 990, PART VI, SECTION B, LINE 11 THE PRESIDENT REVIEWS THE FORM 990 AND PROVIDES COPIES TO THE DIRECTORS BEFORE APPROVING THE FORM FOR SUBMISSION. FORM 990, PART VI, SECTION B, LINE 12C THE PRESIDENT REGULARLY AND CONSISTENTLY MONITORS COMPLIANCE WITH CONFLICTS OF INTEREST BY REQUESTING THAT ALL OFFICERS, DIRECTORS, AND FOUNDERS SIGN AN ANNUAL STATEMENT DISCLOSING ALL INTERESTS THAT MIGHT CONFLICT WITH ANY INTEREST OF THE ORGANIZATION. FORM 990, PART VI, SECTION B, LINE 15 COMPARABILITY DATA IS SUBMITTED ANNUALLY TO THE EXECUTIVE COMMITTEE FOR COMPENSATION APPROVAL FOR THE PRESIDENT AND ALL OTHER EMPLOYEES. FORM 990, PART VI, SECTION C, LINE 19 THE ORGANIZATION'S GOVERNING DOCUMENTS AND CONFLICT OF INTEREST POLICY ARE AVAILABLE UPON REQUEST. THE ORGANIZATION'S FINANCIAL STATEMENTS ARE AVAILABLE UPON REQUEST OR AT THE ORGANIZATION'S WEBSITE.